Wockhardt is currently the top loser on the BSE, down 8.3% at Rs.432.90, with an intra day low at Rs.406. Volumes have spiked up over 2.5 times.

The stock is deep in the red on account of the same issue of US FDA. There is no official word from the company but news floating around that US FDA has issued an import alert for the drug maker's Chikalthana facility at Aurangabad. This is unconfirmed news. Also, the other reason dragging down the stock is that is has been dropped from the MSCI India index, a benchmark global index, effective since yesterday.